Comparative effect of contrast media type on the incidence of contrast-induced nephropathy a systematic review and meta-analysis

Annals of Internal Medicine

Volumn 164, Issue 6, 2016, Pages 417-424

  Eng, John ^a   Wilson, Renee F ^b   Subramaniam, Rathan M ^b   Zhang, Allen ^b   Suarez Cuervo, Catalina ^c   Turban, Sharon ^a   Choi, Michael J ^a   Sherrod, Cheryl ^c   Hutfless, Susan ^a   Iyoha, Emmanuel E ^b   Bass, Eric B ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Johns Hopkins Outpatient Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE; IODIXANOL; LOW OSMOLAR CONTRAST MEDIUM; UNCLASSIFIED DRUG; IODOBENZOIC ACID DERIVATIVE;

COMPARATIVE STUDY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HUMAN; META ANALYSIS; OSMOLALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; EVIDENCE BASED MEDICINE; INCIDENCE; KIDNEY DISEASES; OSMOLARITY; RISK FACTOR;

CONTRAST MEDIA; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; KIDNEY DISEASES; OSMOLAR CONCENTRATION; RISK FACTORS; TRIIODOBENZOIC ACIDS;

EID: 84960862749     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-1402     Document Type: Review

References (59)

1. Kitajima K, Maeda T, Watanabe S, Sugimura K. Recent issues in contrast-induced nephropathy. Int J Urol. 2011; 18: 686-90. [PMID: 21834851] doi: 10.1111/j.1442-2042.2011.02830.x
2. Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal haemodynamics and oxygenation: a role in contrast mediuminduced nephropathy. Nephrol Dial Transplant. 2005; 20 Suppl 1: i6-11. [PMID: 15705946]
3. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005; 68: 14-22. [PMID: 15954892]
4. McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S., et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?. Radiology. 2013; 267: 106-18. [PMID: 23360742] doi: 10.1148/radiol.12121823
5. McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology. 2014; 271: 65-73. [PMID: 24475854] doi: 10.1148/radiol.13130775
6. Fountaine H, Harnish P, Andrew E, Grynne B. Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent. Acad Radiol. 1996; 3 Suppl 3: S475- 84. [PMID: 8883524]
7. Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-Analysis of randomized controlled trials. Radiology. 2009; 250: 68-86. [PMID: 19092091] doi: 10.1148/radiol .2501080833
8. McCullough PA, Brown JR. Effects of intra-Arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrastinduced acute kidney injury: a meta-Analysis. Cardiorenal Med. 2011; 1: 220-234. [PMID: 22164156]
9. Kidney Disease: Improving Global Outcomes Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2: 1-138
10. McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH., et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-Analysis. Radiology. 2013; 267: 119-28. [PMID: 23319662] doi: 10.1148/radiol.12121460
11. Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology. 2013; 267: 94-105. [PMID: 23360737] doi: 10.1148/radiol.12121394
12. Eng J, Subramaniam RM, Wilson RF, Turban S, Choi MJ, Zhang A., et al. Contrast induced nephropathy: comparative effects of different contrast media in patients requiring imaging studies. Rockville, MD: Agency for Healthcare Research and Quality; 2016. [Forthcoming].
13. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Accessed at www .cochrane-handbook.org on 3 June 2015
14. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D., et al. GRADE guidelines 6. Rating the quality of evidence- imprecision. J Clin Epidemiol. 2011; 64: 1283-93. [PMID: 21839614] doi: 10.1016/j.jclinepi.2011.01.012
15. Agency for Healthcare Research and Quality. Methods guide for effectiveness and comparative effectiveness reviews. Publication no. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-Analyses. BMJ. 2003; 327: 557-60. [PMID: 12958120]
17. DerSimonian R, Laird N. Meta-Analysis in clinical trials. Control Clin Trials. 1986; 7: 177-88. [PMID: 3802833]
18. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-Analyses of controlled trials with binary endpoints. Stat Med. 2006; 25: 3443-57. [PMID: 16345038]
19. Becker J, Babb J, Serrano M. Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function. AJR Am J Roentgenol. 2013; 200: 822-6. [PMID: 23521455] doi: 10.2214/AJR.12.8871
20. Dillman JR, al-Hawary M, Ellis JH, Cohan RH, Kaza R, Myles JD., et al. Comparative investigation of I.V. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT. AJR Am J Roentgenol. 2012; 198: 392-7. [PMID: 22268183] doi: 10.2214/AJR.11 .6993
21. Koutsikos D, Konstadinidou I, Mourikis D, Rizos D, Kapetanaki A, Agroyannis B., et al. Contrast media nephrotoxicity: comparison of diatrizoate, ioxaglate, and iohexol after intravenous and renal arterial administration. Ren Fail. 1992; 14: 545-54. [PMID: 1462006]
22. Campbell DR, Flemming BK, Mason WF, Jackson SA, Hirsch DJ, MacDonald KJ. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography. Can Assoc Radiol J. 1990; 41: 133-7. [PMID: 2354386]
23. Jevnikar AM, Finnie KJ, Dennis B, Plummer DT, Avila A, Linton AL. Nephrotoxicity of high- and low-osmolality contrast media. Nephron. 1988; 48: 300-5. [PMID: 3362276]
24. Semerci T, Cuhadar S, Akc?ay FA, Aydin TK, Atay A, Köseoglu M., et al. Comparing the renal safety of isoosmolar versus low-osmolar contrast medium by renal biomarkers N-Acetyl-D-glucosaminidase and endothelin. Angiology. 2014; 65: 108-12. [PMID: 23359781] doi: 10.1177/0003319712469094
25. Limbruno U, Picchi A, Micheli A, Calabria P, Cortese B, Brizi G., et al. Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship. J Cardiovasc Med (Hagerstown). 2014; 15: 587-94. [PMID: 23811842] doi: 10.2459/JCM.0b013 e3283638e56
26. Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F., et al. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial). Am J Cardiol. 2012; 109: 67-74. [PMID: 21943940] doi: 10.1016/j.amjcard.2011.08.006
27. Serafin Z, Karolkiewicz M, Gruszka M, Strózecki P, Lasek W, Odrowaz-Sypniewska G., et al. High incidence of nephropathy in neurosurgical patients after intra-Arterial administration of lowosmolar and iso-osmolar contrast media. Acta Radiol. 2011; 52: 422-9. [PMID: 21498279] doi: 10.1258/ar.2011.100501
28. Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI., et al. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.AmJ Cardiol. 2011; 108: 189-94. [PMID: 21545991] doi: 10.1016/j.amjcard.2011.03.019
29. Zo'o M, Hoermann M, Balassy C, Brunelle F, Azoulay R, Pariente D., et al. Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT. Pediatr Radiol. 2011; 41: 1393-400. [PMID: 21713440] doi: 10.1007/s00247-011-2164-6
30. Chuang FR, Chen TC, Wang IK, Chuang CH, Chang HW, Ting-Yu Chiou T., et al. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study. Ren Fail. 2009; 31: 181-8. [PMID: 19288321] doi: 10.1080/08860220802669636
31. Hernández F, Mora L, García-Tejada J, Velázquez M, Gómez- Blázquez I, Bastante T., et al. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. Rev Esp Cardiol. 2009; 62: 1373-80. [PMID: 20038403]
32. Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H., et al. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-Acetylcysteine and hydration before coronary angiography and intervention: a randomized trial. Intern Med J. 2009; 39: 25-31. [PMID: 18771430] doi: 10.1111/j .1445-5994.2008.01675.x
33. Laskey W, Aspelin P, Davidson C, Rudnick M, Aubry P, Kumar S, et al; DXV405 Study Group. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. Am Heart J.2009; 158: 822-828.e3. [PMID: 19853704] doi: 10.1016/j.ahj.2009.08 .016
34. Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS., et al. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv. 2009; 2: 415-21. [PMID: 19463464] doi: 10.1016/j.jcin.2009.03.007
35. Wessely R, Koppara T, Bradaric C, Vorpahl M, Braun S, Schulz S, et al; Contrast Media and Nephrotoxicity Following Coronary Revascularization by Angioplasty Trial Investigators. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2009; 2: 430-7. [PMID: 20031753] doi: 10.1161/CIRCINTERVENTIONS.109.874933
36. Hardiek KJ, Katholi RE, Robbs RS, Katholi CE. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diabetes Complications. 2008; 22: 171-7. [PMID: 18413220] doi: 10.1016/j.jdiacomp.2006.11.002
37. Kuhn MJ, Chen N, Sahani DV, Reimer D, Van Beek EJ, Heiken JP., et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. AJR Am J Roentgenol. 2008; 191: 151-7. [PMID: 18562739] doi: 10.2214/AJR.07.3370
38. Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA., et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology. 2008; 248: 97-105. [PMID: 18483232] doi: 10 .1148/radiol.2481071484
39. Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX., et al. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Catheter Cardiovasc Interv. 2008; 72: 958-65. [PMID: 19021282] doi: 10.1002/ccd.21713
40. Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/ Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am Heart J. 2008; 156: 776-82. [PMID: 18946896]
41. Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, et al; Investigators of the CARE Study. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007; 115: 3189-96. [PMID: 17562951]
42. Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G., et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006; 41: 815-21. [PMID: 17035872]
43. Feldkamp T, Baumgart D, Elsner M, Herget-Rosenthal S, Pietruck F, Erbel R., et al. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. Clin Nephrol. 2006; 66: 322-30. [PMID: 17140161]
44. Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS., et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol. 2006; 48: 924-30. [PMID: 16949481]
45. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003; 348: 491-9. [PMID: 12571256]
46. Carraro M, Malalan F, Antonione R, Stacul F, Cova M, Petz S., et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol. 1998; 8: 144-7. [PMID: 9442148]
47. Jakobsen JA, Berg KJ, Kjaersgaard P, Kolmannskog F, Nordal KP, Nossen JO., et al. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention. Nephron. 1996; 73: 549-56. [PMID: 8856250]
48. Zhang BC, Wu Q, Wang C, Li DY, Wang ZR. A meta-Analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media. J Cardiol. 2014; 63: 260-8. [PMID: 24397991] doi: 10.1016/j.jjcc.2013.11.021
49. From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-Analysis of randomized, controlled trials. Circ Cardiovasc Interv. 2010; 3: 351-8
50. Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-Analysis of randomized controlled trials. JACC Cardiovasc Interv. 2009; 2: 645-54. [PMID: 19628188] doi: 10 .1016/j.jcin.2009.05.002
51. Dong M, Jiao Z, Liu T, Guo F, Li G. Effect of administration route on the renal safety of contrast agents: a meta-Analysis of randomized controlled trials. J Nephrol. 2012; 25: 290-301. [PMID: 22252847] doi: 10.5301/jn.5000067
52. Biondi-Zoccai G, Lotrionte M, Thomsen HS, Romagnoli E, D'Ascenzo F, Giordano A., et al. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-Analysis. Int J Cardiol. 2014; 172: 375-80. [PMID: 24502883] doi: 10.1016/j.ijcard.2014.01.075
53. Sharma SK, Kini A. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mildmoderate chronic renal insufficiency: pooled analysis of the randomized trials. Catheter Cardiovasc Interv. 2005; 65: 386-93. [PMID: 15926184]
54. McCullough PA, Bertrand ME, Brinker JA, Stacul F. A metaanalysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol. 2006; 48: 692-9. [PMID: 16904536]
55. Hill JA, Winniford M, Cohen MB, Van Fossen DB, Murphy MJ, Halpern EF., et al. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study. Am J Cardiol. 1993; 72: 770-5. [PMID: 8213508]
56. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol. 1999; 72: 701-3. [PMID: 10624328]
57. Newhouse JH, RoyChoudhury A. Quantitating contrast mediuminduced nephropathy: controlling the controls [Editorial]. Radiology. 2013; 267: 4-8. [PMID: 23525714] doi: 10.1148/radiol.13122876
58. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8: R204-12. [PMID: 15312219]
59. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11: R31. [PMID: 17331245]